These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 27525906)
21. X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population. Wu T; Xu YH; Ye XL Tumour Biol; 2013 Oct; 34(5):2611-5. PubMed ID: 23653378 [TBL] [Abstract][Full Text] [Related]
22. Association of XRCC1 polymorphisms with thyroid cancer risk. Wang C; Ai Z Tumour Biol; 2014 May; 35(5):4791-7. PubMed ID: 24477575 [TBL] [Abstract][Full Text] [Related]
23. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis. Chi XX; Liu YY; Shi SN; Cong Z; Liang YQ; Zhang HJ Mol Vis; 2015; 21():335-46. PubMed ID: 25873778 [TBL] [Abstract][Full Text] [Related]
24. XRCC1 Arg194Trp and Arg280His polymorphisms in bladder cancer susceptibility: a meta-analysis. Liu C; Yin Q; Li L; Jiao G; Wang M; Wang Y Crit Rev Eukaryot Gene Expr; 2013; 23(4):339-54. PubMed ID: 24266849 [TBL] [Abstract][Full Text] [Related]
25. The polymorphism of XRCC1 and coronary artery disease risk: a meta-analysis. Guo SJ; Zhou YT; Liu WY; Zuo QN; Li XH Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1559-1567. PubMed ID: 28429350 [TBL] [Abstract][Full Text] [Related]
26. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis. Wei X; Chen D; Lv T Mol Biol Rep; 2013 Jan; 40(1):567-72. PubMed ID: 23096083 [TBL] [Abstract][Full Text] [Related]
27. XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Huang Y; Li L; Yu L Mutagenesis; 2009 Jul; 24(4):331-9. PubMed ID: 19465687 [TBL] [Abstract][Full Text] [Related]
28. DNA repair gene X-ray repair cross complementing group 1 Arg194Trp polymorphism on the risk of lung cancer: a meta-analysis on 22 studies. Jiang J; Liang X; Zhou X; Huang R; Chu Z; Zhan Q; Lin H J Thorac Oncol; 2010 Nov; 5(11):1741-7. PubMed ID: 20975374 [TBL] [Abstract][Full Text] [Related]
29. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis. Liu DY; Liang HC; Xiao XM Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915 [TBL] [Abstract][Full Text] [Related]
30. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking. Schneider J; Classen V; Bernges U; Philipp M Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409 [TBL] [Abstract][Full Text] [Related]
31. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697 [TBL] [Abstract][Full Text] [Related]
32. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies. Wu K; Su D; Lin K; Luo J; Au WW Asian Pac J Cancer Prev; 2011; 12(9):2237-43. PubMed ID: 22296363 [TBL] [Abstract][Full Text] [Related]
33. Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis. Yang D; Liu C; Shi J; Wang N; Du X; Yin Q; Wang Y Gene; 2014 Jan; 534(1):17-23. PubMed ID: 24176953 [TBL] [Abstract][Full Text] [Related]
34. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210 [TBL] [Abstract][Full Text] [Related]
35. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies. Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255 [TBL] [Abstract][Full Text] [Related]
36. Genetic Association of XRCC1 Gene rs1799782, rs25487 and rs25489 Polymorphisms with Risk of Thyroid Cancer: a Systematic Review and Meta-Analysis. Jafari Nedooshan J; Forat Yazdi M; Neamatzadeh H; Zare Shehneh M; Kargar S; Seddighi N Asian Pac J Cancer Prev; 2017 Jan; 18(1):263-270. PubMed ID: 28240845 [TBL] [Abstract][Full Text] [Related]
37. Study on the association between the Arg194Trp polymorphism in the XRCC1 gene and the risk of hematological malignancies. Tang L; Xiong T; Jia Q; He Q; Tong X; Peng Y; Shen J; Yang J; Zhang Y Tumour Biol; 2014 Apr; 35(4):3009-16. PubMed ID: 24414482 [TBL] [Abstract][Full Text] [Related]
38. Effect of X-ray repair cross complementing group 1 polymorphisms on the efficacy of platinum-based chemotherapy in patients with nonsmall cell lung cancer. Fan X; Xiu Q J Cancer Res Ther; 2015; 11(3):571-4. PubMed ID: 26458583 [TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a meta-analysis. Zhang H; Li W; Franklin MJ; Dudek AZ Anticancer Res; 2011 Nov; 31(11):3945-52. PubMed ID: 22110224 [TBL] [Abstract][Full Text] [Related]
40. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk. Dong LM; Zhang XY; Teng H; Li MS; Wang P Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]